Sign in
8-K

Current Report

Avalo Therapeutics, Inc. Filed Acc 0001628280-20-008754

Results of operations · Other events

  • Item 2.02 Results of operations and financial condition
  • Item 8.01 Other events

From the SEC's structured data for this filing

Loading a8-kinvestorpresentation_j.htm…